Differential Regulation of Interferon Synoviocyte Innate Immune Responses: I
暂无分享,去创建一个
[1] M. Feldmann,et al. Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems. , 2007, Blood.
[2] Jiahuai Han,et al. Differential requirement of MKK4 and MKK7 in JNK activation by distinct scaffold proteins , 2007, FEBS letters.
[3] C. Tournier,et al. Physiological roles of MKK4 and MKK7: insights from animal models. , 2006, Biochimica et biophysica acta.
[4] C. Vinson,et al. Interleukin‐1β and tetradecanoylphorbol acetate‐induced biosynthesis of tumor necrosis factor α in human hepatoma cells involves the transcription factors ATF2 and c‐Jun and stress‐activated protein kinases , 2007 .
[5] G. Firestein,et al. Regulation of JNK by MKK-7 in fibroblast-like synoviocytes. , 2006, Arthritis and rheumatism.
[6] L. O’Neill,et al. Targeting signal transduction as a strategy to treat inflammatory diseases , 2006, Nature Reviews Drug Discovery.
[7] M. David,et al. Cutting Edge: Apoptosis-Regulating Signal Kinase 1 Is Required for Reactive Oxygen Species-Mediated Activation of IFN Regulatory Factor 3 by Lipopolysaccharide1 , 2006, The Journal of Immunology.
[8] S. Kohsaka,et al. Nonparticipation of nuclear factor kappa B (NFκB) in the signaling cascade of c-Jun N-terminal kinase (JNK)- and p38 mitogen-activated protein kinase (p38MAPK)-dependent tumor necrosis factor alpha (TNFα) induction in lipopolysaccharide (LPS)-stimulated microglia , 2006, Brain Research.
[9] R. Gay,et al. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. , 2005, Arthritis and rheumatism.
[10] Michael McClelland,et al. Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. , 2004, Molecular cell.
[11] Tom Maniatis,et al. Crystal structure of ATF‐2/c‐Jun and IRF‐3 bound to the interferon‐β enhancer , 2004 .
[12] Francesca Zazzeroni,et al. Gadd45β mediates the NF-κB suppression of JNK signalling by targeting MKK7/JNKK2 , 2004, Nature Cell Biology.
[13] W. Bugbee,et al. Quantitative biomarker analysis of synovial gene expression by real-time PCR , 2003, Arthritis research & therapy.
[14] G. Firestein,et al. Expression of the MAPK kinases MKK-4 and MKK-7 in rheumatoid arthritis and their role as key regulators of JNK. , 2003, Arthritis and rheumatism.
[15] Guo-Ping Zhou,et al. Triggering the Interferon Antiviral Response Through an IKK-Related Pathway , 2003, Science.
[16] G. Firestein. Evolving concepts of rheumatoid arthritis , 2003, Nature.
[17] T. Maniatis,et al. IKKε and TBK1 are essential components of the IRF3 signaling pathway , 2003, Nature Immunology.
[18] E. Pieterman,et al. Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair , 2003, Genes and Immunity.
[19] J. Hiscott,et al. Identification of the Minimal Phosphoacceptor Site Required for in Vivo Activation of Interferon Regulatory Factor 3 in Response to Virus and Double-stranded RNA* , 2003, The Journal of Biological Chemistry.
[20] A. Masuda,et al. Th2 Cytokine Production from Mast Cells Is Directly Induced by Lipopolysaccharide and Distinctly Regulated by c-Jun N-Terminal Kinase and p38 Pathways1 , 2002, The Journal of Immunology.
[21] J. Hiscott,et al. Multiple signaling pathways leading to the activation of interferon regulatory factor 3. , 2002, Biochemical pharmacology.
[22] C. Brinckerhoff,et al. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors , 2001, Arthritis Research & Therapy.
[23] M. Yoneyama,et al. Control of IRF-3 activation by phosphorylation. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[24] T. Mak,et al. The Stress Kinase Mitogen-Activated Protein Kinase Kinase (Mkk)7 Is a Negative Regulator of Antigen Receptor and Growth Factor Receptor–Induced Proliferation in Hematopoietic Cells , 2001, The Journal of experimental medicine.
[25] P. Ruvolo. Ceramide regulates cellular homeostasis via diverse stress signaling pathways , 2001, Leukemia.
[26] M. Karin,et al. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. , 2001, The Journal of clinical investigation.
[27] R. Flavell,et al. MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. , 2001, Genes & development.
[28] M. Yoneyama,et al. Induction of IRF‐3/‐7 kinase and NF‐κB in response to double‐stranded RNA and virus infection: common and unique pathways , 2001, Genes to cells : devoted to molecular & cellular mechanisms.
[29] J. C. Pratt,et al. Role of MEKK2-MEK5 in the regulation of TNF-α gene expression and MEKK2-MKK7 in the activation of c-Jun N-terminal kinase in mast cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Hiscott,et al. Identification of Distinct Signaling Pathways Leading to the Phosphorylation of Interferon Regulatory Factor 3* , 2001, The Journal of Biological Chemistry.
[31] Qingbo Xu,et al. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. , 2000, Arthritis and rheumatism.
[32] Tom Maniatis,et al. Assembly of a Functional Beta Interferon Enhanceosome Is Dependent on ATF-2–c-jun Heterodimer Orientation , 2000, Molecular and Cellular Biology.
[33] J. Yim,et al. Signaling pathways to the assembly of an interferon-beta enhanceosome. Chemical genetic studies with a small molecule. , 2000, The Journal of biological chemistry.
[34] A. Cuenda. Mitogen-activated protein kinase kinase 4 (MKK4). , 2000, The international journal of biochemistry & cell biology.
[35] A. Manning,et al. Jun N-terminal kinase in rheumatoid arthritis. , 1999, The Journal of pharmacology and experimental therapeutics.
[36] J. Hiscott,et al. Structural and Functional Analysis of Interferon Regulatory Factor 3: Localization of the Transactivation and Autoinhibitory Domains , 1999, Molecular and Cellular Biology.
[37] J. Hiscott,et al. Virus-Dependent Phosphorylation of the IRF-3 Transcription Factor Regulates Nuclear Translocation, Transactivation Potential, and Proteasome-Mediated Degradation , 1998, Molecular and Cellular Biology.
[38] T. Maniatis,et al. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. , 1998, Molecular cell.
[39] J. V. Falvo,et al. Structure and Function of the Interferon-β Enhanceosome , 1998 .
[40] T. Mak,et al. Impaired CD28-mediated Interleukin 2 Production and Proliferation in Stress Kinase SAPK/ERK1 Kinase (SEK1)/Mitogen-activated Protein Kinase Kinase 4 (MKK4)-deficient T Lymphocytes , 1997, The Journal of experimental medicine.
[41] M. Cobb,et al. Mitogen-activated protein kinase pathways. , 1997, Current opinion in cell biology.
[42] G. Firestein,et al. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids. , 1991, Arthritis and rheumatism.
[43] G. Firestein,et al. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. , 1990, The Journal of clinical investigation.
[44] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.